Side effects and watch-outs
- Injection site reaction
- Nausea (uncommon)
- Headache
- Very limited long-term human data
- Same theoretical tumour angiogenesis concern as BPC-157
Peptide / Repair
Pentadeca Arginate (PDA)
Novel BPC-157 analog. Enhanced stability and superior blood-brain barrier penetration. More resistant to gastric acid. May equal or exceed BPC-157 healing effects.
Educational reference only. This page does not diagnose, prescribe, or replace care from a licensed professional. Laws, availability, and clinical appropriateness vary by location.